FRA:VIH1 (Germany)
Â
Registered Shares
€
10.22
(-2.85%)
Jun 12
New Key Statistics Module, Z-Score and F-Score
FRA:VIH1 Key Ratios
| Market Cap € M | 337.82 |
| Enterprise Value € M | 1,161.95 |
| P/E(ttm) | 9,999.00 |
| PE Ratio without NRI | 9,999.00 |
| Forward PE Ratio | -- |
| Price/Book | 0.39 |
| Price/Sales | 3.06 |
| Price/Free Cash Flow | 4.43 |
| Price/Owner Earnings | 1.82 |
| Payout Ratio % | -- |
| Revenue (TTM) € M | 108.00 |
| EPS (TTM) € | -- |
| Beneish M-Score | 34.3 |
| 10-y EBITDA Growth Rate % | 7.30 |
| 5-y EBITDA Growth Rate % | 11.10 |
| y-y EBITDA Growth Rate % | 70.90 |
| EV-to-EBIT | 6.38 |
| EV-to-EBITDA | 5.51 |
| PEG | -- |
| Shares Outstanding M | 33.05 |
| Net Margin (%) | -- |
| Operating Margin % | -- |
| Pre-tax Margin (%) | -- |
| Quick Ratio | 7.86 |
| Current Ratio | 7.86 |
| ROA % (ttm) | -- |
| ROE % (ttm) | -- |
| ROIC % (ttm) | -- |
| Dividend Yield % | -- |
| Altman Z-Score | 0.89 |
FRA:VIH1 Number of Guru Trades
FRA:VIH1 Volume of Guru Trades
Gurus Latest Trades with FRA:VIH1
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
FRA:VIH1 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers